RUNNING POINT CAPITAL ADVISORS, LLC Aerie Pharmaceuticals, Inc. Transaction History

RUNNING POINT CAPITAL ADVISORS, LLC portfolio value:

$0
portfolio value

RUNNING POINT CAPITAL ADVISORS, LLC quarter portfolio value change:

+101.73%
quarter

Aerie Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -10.74K shares -81K $15.13 0
Q2 2022 share Decrease -0.98% -106 shares -18K $7.5 10.74K
Q1 2022 share Increase 0.00% 10.84K shares 99K $9.1 10.84K